¿El estrés provoca úlceras?

Esto es lo que dicen los expertos sobre el estrés y otros factores de riesgo para las úlceras.

Hace casi un año se aprobó un fármaco para frenar el alzhéimer. ¿Ha funcionado?

Mientras la FDA estudia otro nuevo medicamento contra el alzhéimer, preguntamos a los expertos qué impacto ha tenido el uso del lecanemab en sus pacientes.

How A.I. Is Revolutionizing Drug Development

In high-tech labs, workers are generating data to train A.I. algorithms to design better medicine, faster. But the transformation is just getting underway.

Does Stress Cause Ulcers?

Here’s what the evidence suggests about this long-running claim.

Akira Endo, Scholar of Statins That Reduce Heart Disease, Dies at 90

The Japanese biochemist found in the 1970s that cholesterol-lowering drugs lowered the LDL, or “bad” cholesterol, level in the blood.

Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug

The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.

Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and Benefits

As the F.D.A. considers a new Alzheimer’s medication, we asked experts how the rollout of a similar drug has gone.

New Covid Vaccine Endorsed for Fall

The panel endorsed targeting a variant of the coronavirus that is now receding, though some officials suggested aiming at newer versions of the virus that have emerged in recent weeks.

FDA Panel Rejects Use of MDMA for Treatment of PTSD

An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.

Why PTSD Is So Hard to Diagnose and Treat

The F.D.A. is weighing whether to approve MDMA-assisted therapy as a new option.